Home » Market News » DirectorsTalk Highlights » We need medical innovation for things besides COVID-19
Allergy therapeutics plc

We need medical innovation for things besides COVID-19

I’ve had to keep a close eye on my son his whole life. He suffers from a severe tree nut allergy, making things like birthday parties, school events or any gathering where food might be involved a cause for concern.

I hope that one day this allergy will be a thing of the past. However, there is more research to be done and more progress to be made until that’s the case.

Now we both face an even larger threat due to COVID-19. We’re cooped up just like everyone else, social distancing to keep us both safe. But what if this isn’t enough? One of us could still get sick despite our best efforts, and his chances are far better than mine are.

Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.